½ÃÀ庸°í¼­
»óǰÄÚµå
1676244

¼¼°èÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2033³â)

Global Patient Monitoring Device Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 138 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ±Ô¸ð´Â 2024³â 565¾ï 3,000¸¸ ´Þ·¯¿¡¼­ 2033³â¿¡´Â 1,131¾ï 7,000¸¸ ´Þ·¯·Î ¼ºÀåÇϸç, 2026-2033³âÀÇ ¿¹Ãø ±â°£ Áß 8.02%ÀÇ °ß°íÇÑ ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í Áö¼ÓÀûÀÎ °Ç°­ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ°í º´¿ø ÀçÀÔ¿øÀ» ÁÙÀ̱â À§ÇØ Ã·´Ü ¸ð´ÏÅ͸µ ±â±âÀÇ µµÀÔÀÌ ÇʼöÀûÀÔ´Ï´Ù. ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅÍ, ½ÉÀå ¸ð´ÏÅÍ, ¸ÖƼÆÄ¶ó¹ÌÅÍ ¸ð´ÏÅ͸¦ Æ÷ÇÔÇÑ ÀÌ·¯ÇÑ Àåºñ´Â ÀÇ·á Àü¹®°¡°¡ ȯÀÚÀÇ °Ç°­ ÁöÇ¥¸¦ ½Ç½Ã°£À¸·Î ÃßÀûÇÏ¿© Àû½Ã¿¡ °³ÀÔÇÏ°í °³º°È­µÈ Ä¡·á¸¦ ÃËÁøÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

¶ÇÇÑ ¹«¼± ±â¼ú°ú ¿¬°á¼ºÀÇ ¹ßÀüÀº ȯÀÚ ¸ð´ÏÅ͸µ Àåºñ ½ÃÀå¿¡ º¯È­¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. »ç¹°ÀÎÅͳÝ(IoT) ±â´ÉÀÇ ÅëÇÕÀ¸·Î ¿øÈ°ÇÑ µ¥ÀÌÅÍ Àü¼Û°ú ¿ø°Ý ¸ð´ÏÅ͸µÀÌ °¡´ÉÇØÁö¸é¼­ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ¾îµð¼­³ª ȯÀÚ Á¤º¸¿¡ Á¢±ÙÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ°ú °Ç°­ ¹®Á¦ÀÇ ¿¹¹æÀû °ü¸®°¡ °¡´ÉÇϹǷΠ¸¸¼ºÁúȯ ȯÀÚ °ü¸®¿¡ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. ¶ÇÇÑ ¿ø°ÝÀÇ·áÀÇ ºÎ»óÀ¸·Î ÀÎÇØ ȯÀÚ ¸ð´ÏÅ͸µ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀº ȯÀÚ¿ÍÀÇ °ü°è¸¦ °­È­Çϰí Ä¡·á Á¢±Ù¼ºÀ» Çâ»ó½Ã۱â À§ÇØ ¿ø°Ý ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³ôÀ̰í Àֱ⠶§¹®ÀÔ´Ï´Ù.

¶ÇÇÑ È¯ÀÚ Á᫐ ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡µµ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ȯÀÚ°¡ ÀÇ·á °áÁ¤¿¡ Âü¿©ÇÔ¿¡ µû¶ó °³ÀÎÀÌ Áý¿¡¼­ ÀÚ½ÅÀÇ °Ç°­À» ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½º¸¶Æ®¿öÄ¡, ÇÇÆ®´Ï½º Æ®·¡Ä¿¿Í °°Àº ¿þ¾î·¯ºí ±â±â´Â »ç¿ëÀÚ¿¡°Ô °Ç°­°ú À£ºù¿¡ ´ëÇÑ ±ÍÁßÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇϹǷΠÀα⸦ ²ø°í ÀÖ½À´Ï´Ù. ±â¼ú ±â¾÷°ú ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õÀÇ Çù¾÷Àº Çõ½ÅÀ» ÃËÁøÇϰí, ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎÀÇ ¿ä±¸¸¦ ÃæÁ·½ÃŰ´Â »ç¿ëÀÚ Ä£È­ÀûÀÎ ±â±â¸¦ °³¹ßÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù.

´ç»çÀÇ º¸°í¼­´Â °í°´¿¡°Ô ´Ù¾çÇÑ »ê¾÷ ¹× ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÌ°í ½Ç¿ëÀûÀÎ ÀλçÀÌÆ®¸¦ Á¦°øÇϱâ À§ÇØ ¼¼½ÉÇÏ°Ô ÀÛ¼ºµÇ¾ú½À´Ï´Ù. °¢ º¸°í¼­´Â ½ÃÀå »óȲÀ» ¿ÏÀüÈ÷ ÀÌÇØÇϱâ À§ÇØ ¸î °¡Áö Áß¿äÇÑ ¿ä¼Ò¸¦ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä : ½ÃÀå °³¿ä : Á¤ÀÇ, ºÐ·ù, »ê¾÷ ÇöȲ µî ½ÃÀå¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ¼Ò°³.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ: ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× °úÁ¦¸¦ »ó¼¼ÇÏ°Ô ºÐ¼®ÇÕ´Ï´Ù. ÀÌ ¼½¼Ç¿¡¼­´Â ±â¼ú ¹ßÀü, ±ÔÁ¦ º¯È­, »õ·Î¿î µ¿Çâ µîÀÇ ¿äÀÎÀ» °ËÅäÇÕ´Ï´Ù.

¼¼ºÐÈ­ ºÐ¼® : Á¦Ç° À¯Çü, ¾ÖÇø®ÄÉÀ̼Ç, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ª µîÀÇ ±âÁØ¿¡ µû¶ó ½ÃÀåÀ» ¸íÈ®ÇÑ ºÎ¹®À¸·Î ºÐ·ùÇÕ´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ °¢ ºÎ¹®ÀÇ ¼º°ú¿Í ÀáÀç·ÂÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

°æÀï»óȲ: ½ÃÀå Á¡À¯À², Á¦Ç° Æ÷Æ®Æú¸®¿À, Àü·«Àû ±¸»ó, À繫½ÇÀû µî ÁÖ¿ä ½ÃÀå ÁøÀÔ±â¾÷¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Æò°¡. ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇϰí ÀÖ´Â °æÀï ¿ªÇÐ ¹× ÁÖ¿ä Àü·«¿¡ ´ëÇÑ ÀλçÀÌÆ®ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

½ÃÀå ¿¹Ãø : °ú°Å µ¥ÀÌÅÍ¿Í ÇöÀç ½ÃÀå »óȲÀ» ¹ÙÅÁÀ¸·Î ÀÏÁ¤ ±â°£ Áß ½ÃÀå ±Ô¸ð¿Í ¼ºÀå Ãß¼¼¸¦ ¿¹ÃøÇÕ´Ï´Ù. ¿©±â¿¡´Â Á¤·®Àû ºÐ¼®°ú ¹Ì·¡ ½ÃÀå ±ËÀûÀ» ³ªÅ¸³»´Â ±×·¡ÇÁ Ç¥½Ã°¡ Æ÷ÇԵ˴ϴÙ.

Áö¿ª ºÐ¼® : Áö¿ªº° ½ÃÀå ¼º°ú¸¦ Æò°¡Çϰí ÁÖ¿ä ½ÃÀå ¹× Áö¿ª µ¿ÇâÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. Áö¿ª ½ÃÀå ¿ªÇÐ ¹× ºñÁî´Ï½º ±âȸ¸¦ ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

»õ·Î¿î µ¿Çâ°ú ±âȸ: ÇöÀç ½ÃÀå µ¿Çâ°ú »õ·Î¿î ½ÃÀå µ¿Çâ, ±â¼ú Çõ½Å, ÀáÀçÀû ÅõÀÚ ´ë»ó ºÎ¹®À» ½Äº°ÇÕ´Ï´Ù. ¹Ì·¡ ½ÃÀå °³¹ß ¹× ¼ºÀå Àü¸Á¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå °³¿ä

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ½º³À¼ô

Á¦3Àå ȯÀÚ ¸ð´ÏÅ͸µ ±â±â »ê¾÷ ºÐ¼®

  • ¼­·Ð : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • »ê¾÷ µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿ø·á ºÐ¼®
    • ¿ø·á ¸®½ºÆ®
    • ¿ø·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿ø·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¼¼°èÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ºÐ¼® : Á¦Ç°º°

  • Á¦Ç°º° °³¿ä
  • Á¦Ç°º° °ú°Å¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • ½ÉÀå ¸ð´ÏÅ͸µ ±â±â(À̽ÄÇü ·çÇÁ ¸®ÄÚ´õ, ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ¸ð´ÏÅÍ, ½º¸¶Æ® ¿þ¾î·¯ºí ECG ÆÐÄ¡)
  • ½Å°æ ¸ð´ÏÅ͸µ ±â±â(EEG ±â±â, ³ú³» »ê¼Ò ³óµµ°è, µÎ°³³»¾Ð ¸ð´ÏÅÍ, EMG ±â±â)
  • È£Èí ¸ð´ÏÅ͸µ ±â±â(ÆÞ½º¿Á½Ã¹ÌÅÍ, ½ºÆÄÀ̷ιÌÅÍ, Ä«ÇÁ³ë±×·¡ÇÁ, ÇÇÅ© ÇÃ·Î¿ì ¹ÌÅÍ)
  • ¸¶Ãë ¸ð´ÏÅÍ
  • Ç÷ÇൿÅ ¸ð´ÏÅ͸µ ±â±â
  • ÅÂ¾Æ¿Í ½Å»ý¾Æ ¸ð´ÏÅ͸µ
  • ¸ÖƼÆÄ¶ó¹ÌÅÍ ¸ð´ÏÅ͸µ ±â±â
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ºÐ¼® : À¯Çüº°

  • À¯Çüº° °³¿ä
  • À¯Çüº° °ú°Å¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • ¹«¼± ¼¾¼­ ±â¼ú
  • ¸ð¹ÙÀÏ Çコ
  • ÅÚ·¹Çコ
  • ¿þ¾î·¯ºí ±â±â
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

  • ÃÖÁ¾ ¿ëµµº° °³¿ä
  • ÃÖÁ¾ ¿ëµµº° °ú°Å¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ÀçÅà ÀÇ·á
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹Ì ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º° ¸®½ºÆ®
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ±â¾÷ÀÇ °æÀï ±¸µµ

  • ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ °æÀï
  • Á¦ÈÞ/Çù·Â/ÇÕÀÇ
  • ÇÕº´¡¤Àμö
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦10Àå ±â¾÷ °³¿ä

  • »óÀ§ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Nihon Kohden
  • Natus Medical
  • Edward Lifesciences
  • Omron
  • Masimo
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Hill-Rom Holdings
  • DraGerwerk AG
  • Shenzhen Mindray Bio-Medical Electronics
  • Compumedics
KSA 25.04.10

Global Patient Monitoring Device Market size is anticipated to grow from USD 56.53 Billion in 2024 to USD 113.17 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.02% during the forecast period of 2026 to 2033.

Patient Monitoring Device Market The patient monitoring device market is experiencing significant growth, driven by the increasing prevalence of chronic diseases and the rising demand for continuous health monitoring. As healthcare providers seek to improve patient outcomes and reduce hospital readmissions, the adoption of advanced monitoring devices is becoming essential. These devices, which include vital sign monitors, cardiac monitors, and multi-parameter monitors, enable healthcare professionals to track patients' health metrics in real-time, facilitating timely interventions and personalized care.

Moreover, advancements in wireless technology and connectivity are transforming the patient monitoring device market. The integration of Internet of Things (IoT) capabilities allows for seamless data transmission and remote monitoring, enabling healthcare providers to access patient information from anywhere. This trend is particularly beneficial in managing patients with chronic conditions, as it allows for continuous monitoring and proactive management of health issues. Additionally, the rise of telemedicine is further driving the demand for patient monitoring devices, as healthcare providers increasingly rely on remote monitoring solutions to enhance patient engagement and access to care.

Furthermore, the growing emphasis on patient-centered care is influencing the patient monitoring device market. As patients become more involved in their healthcare decisions, there is a rising demand for devices that empower individuals to monitor their health at home. Wearable devices, such as smartwatches and fitness trackers, are gaining popularity as they provide users with valuable insights into their health and wellness. The collaboration between technology companies and healthcare providers is fostering innovation, leading to the development of user-friendly devices that cater to the needs of both patients and healthcare professionals.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Analysis

  • Cardiac monitoring devices(Implantable loop recorders, Mobile cardiac telemetry monitors, Smart wearable ECG patches)
  • Neuromonitoring devices(EEG devices, Cerebral oximeters, Intracranial pressure monitors, EMG devices)
  • Respiratory monitoring devices(Pulse oximeters, Spirometers, Capnographs, Peak flow meters)
  • Anesthesia monitor
  • Hemodynamic monitoring devices
  • Fetal and neonatal monitoring
  • Multiparameter monitoring devices
  • Others

By Type Analysis

  • Wireless Sensor Technology
  • MHealth
  • Telehealth
  • Wearable Devices
  • Others

By End use Analysis

  • Hospitals
  • Ambulatory surgical centers
  • Homecare settings
  • Others
  • COMPANIES PROFILED
  • Nihon Kohden
  • Natus Medical
  • Edward Lifesciences
  • Omron
  • Masimo
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Hill-Rom Holdings
  • Dragerwerk AG
  • Shenzhen Mindray Bio-Medical Electronics
  • Compumedics.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PATIENT MONITORING DEVICE INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Type
    • 3.7.3 Market Attractiveness Analysis By End Use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PATIENT MONITORING DEVICE MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Cardiac Monitoring Devices (Implantable Loop Recorders, Mobile Cardiac Telemetry Monitors, Smart Wearable ECG Patches) Historic and Forecast Sales By Regions
  • 5.4. Neuromonitoring Devices (EEG Devices, Cerebral Oximeters, Intracranial Pressure Monitors, EMG Devices) Historic and Forecast Sales By Regions
  • 5.5. Respiratory Monitoring Devices (Pulse Oximeters, Spirometers, Capnographs, Peak Flow Meters) Historic and Forecast Sales By Regions
  • 5.6. Anesthesia Monitor Historic and Forecast Sales By Regions
  • 5.7. Hemodynamic Monitoring Devices Historic and Forecast Sales By Regions
  • 5.8. Fetal And Neonatal Monitoring Historic and Forecast Sales By Regions
  • 5.9. Multiparameter Monitoring Devices Historic and Forecast Sales By Regions
  • 5.10. Others Historic and Forecast Sales By Regions

6. GLOBAL PATIENT MONITORING DEVICE MARKET ANALYSIS BY TYPE

  • 6.1. Overview By Type
  • 6.2. Historical and Forecast Data Analysis By Type
  • 6.3. Wireless Sensor Technology Historic and Forecast Sales By Regions
  • 6.4. Mhealth Historic and Forecast Sales By Regions
  • 6.5. Telehealth Historic and Forecast Sales By Regions
  • 6.6. Wearable Devices Historic and Forecast Sales By Regions
  • 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL PATIENT MONITORING DEVICE MARKET ANALYSIS BY END USE

  • 7.1. Overview By End Use
  • 7.2. Historical and Forecast Data Analysis By End Use
  • 7.3. Hospitals Historic and Forecast Sales By Regions
  • 7.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 7.5. Homecare Settings Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL PATIENT MONITORING DEVICE MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PATIENT MONITORING DEVICE COMPANIES

  • 9.1. Patient Monitoring Device Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF PATIENT MONITORING DEVICE INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Nihon Kohden
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Natus Medical
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Edward Lifesciences
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Omron
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Masimo
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. GE Healthcare
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Koninklijke Philips N.V.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Hill-Rom Holdings
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. DräGerwerk AG
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Shenzhen Mindray Bio-Medical Electronics
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Compumedics
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦